adenine has been researched along with mpi-0479605 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baichwal, V; Carlson, RO; Cassiano, J; Christophe, H; Cimbora, DM; Davis, T; Dorweiler, I; Douce, TB; Hess, MA; Kumar, DV; McAlexander, I; McKinnon, R; Ostanin, K; Papac, DI; Peterson, A; Robinson, R; Rogers, A; Roth, BL; Saunders, M; Tardif, KD; Wettstein, DA; Willardsen, JA; Williams, BL | 1 |
| Bradford, C; Bursavich, M; Carlson, RO; Chan, A; Cimbora, DM; Gerrish, D; Hoarau, C; McKinnon, R; Papac, DI; Patton, S; Reeves, L; Roth, BL; Saunders, M; Shenderovich, M; Slattum, P; Vijay Kumar, D; Williams, BL; Yager, K | 1 |
2 other study(ies) available for adenine and mpi-0479605
| Article | Year |
|---|---|
Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1.
Topics: Adenine; Animals; Antineoplastic Agents; Cell Line, Tumor; HCT116 Cells; Humans; Mice; Mice, Nude; Mitosis; Models, Biological; Molecular Weight; Morpholines; Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Small Molecule Libraries; Xenograft Model Antitumor Assays | 2011 |
Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors.
Topics: Adenine; Administration, Oral; Animals; Apoptosis; Binding Sites; Crystallography, X-Ray; G2 Phase Cell Cycle Checkpoints; HCT116 Cells; Humans; M Phase Cell Cycle Checkpoints; Mice; Molecular Conformation; Morpholines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Purines; Structure-Activity Relationship | 2012 |